Psoriasis Knowledge Centre relaunches on Medthority.com
The Psoriasis Knowledge Centre provides a comprehensive guide to the condition, delving into established topical, systemic and biologic treatments available for psoriasis as well as novel treatments, such as TNFα and interleukin antagonists.
You can delve into topics which uncover Disease Awareness, enabling you to learn about the trigger factors, comorbidities, the burden of psoriasis and the role of cytokines.
Read more about guidelines and management information on how to measure the response to treatment.
Discover how recent advances mean there are a number of new treatments available which target different signalling pathways including both TNFα inhibitors and interleukin-based therapies.
When it comes to psoriasis, a knowledgeable healthcare professional is highly valued by patients (Pariser et al., 2016). With this in mind, we created The Psoriasis Academy, an online hub featuring succinct and easily accessible information for all healthcare professionals who want to know more about psoriasis and keep up to date with the latest developments.
Related news and insights
UCB announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has granted marketing authorization for Bimezlx (bimekizumab) for the treatment of plaque psoriasis, generalized pustular psoriasis and psoriatic erythroderma in patients who are not sufficiently responding to existing treatments.
Dermavant Sciences announced that new patient satisfaction data from PSOARING 3, the long-term extension study of tapinarof cream for the treatment of plaque psoriasis in adults, will be presented at the 2022 Winter Clinical Dermatology Conference, to be held Jan.